Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 186

1.

Utility of testing patients, on presentation, for serologic features of celiac disease.

Srinivas M, Basumani P, Podmore G, Shrimpton A, Bardhan KD.

Clin Gastroenterol Hepatol. 2014 Jun;12(6):946-52. doi: 10.1016/j.cgh.2013.10.037. Epub 2013 Nov 19.

PMID:
24262940
2.

Clinical and histopathological correlation of duodenal biopsy with IgA anti-tissue transglutaminase titers in children with celiac disease.

Bhattacharya M, Lomash A, Sakhuja P, Dubey AP, Kapoor S.

Indian J Gastroenterol. 2014 Jul;33(4):350-4. doi: 10.1007/s12664-014-0464-0. Epub 2014 May 24.

PMID:
24859392
3.

Defining thresholds of antibody levels improves diagnosis of celiac disease.

Vermeersch P, Geboes K, Mariën G, Hoffman I, Hiele M, Bossuyt X.

Clin Gastroenterol Hepatol. 2013 Apr;11(4):398-403; quiz e32. doi: 10.1016/j.cgh.2012.10.025. Epub 2012 Oct 25.

PMID:
23103822
4.

Diagnosis of celiac disease in adults based on serology test results, without small-bowel biopsy.

Wakim-Fleming J, Pagadala MR, Lemyre MS, Lopez R, Kumaravel A, Carey WD, Zein NN.

Clin Gastroenterol Hepatol. 2013 May;11(5):511-6. doi: 10.1016/j.cgh.2012.12.015. Epub 2013 Jan 7.

PMID:
23305824
5.

Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests.

Akbari MR, Mohammadkhani A, Fakheri H, Javad Zahedi M, Shahbazkhani B, Nouraie M, Sotoudeh M, Shakeri R, Malekzadeh R.

Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1181-6.

PMID:
17033439
6.

Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?

Lock RJ, Stevens S, Pitcher MC, Unsworth DJ.

Eur J Gastroenterol Hepatol. 2004 May;16(5):467-70.

PMID:
15097038
7.

Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease.

Alessio MG, Tonutti E, Brusca I, Radice A, Licini L, Sonzogni A, Florena A, Schiaffino E, Marus W, Sulfaro S, Villalta D; Study Group on Autoimmune Diseases of Italian Society of Laboratory Medicine..

J Pediatr Gastroenterol Nutr. 2012 Jul;55(1):44-9. doi: 10.1097/MPG.0b013e3182470249.

PMID:
22197946
8.

Limited utilization of serologic testing in patients undergoing duodenal biopsy for celiac disease.

Wiland HO 4th, Henricks WH, Daly TM.

BMC Gastroenterol. 2013 Nov 9;13:156. doi: 10.1186/1471-230X-13-156.

9.

Positive predictive value of serological diagnostic measures in celiac disease.

Toftedal P, Nielsen C, Madsen JT, Titlestad K, Husby S, Lillevang ST.

Clin Chem Lab Med. 2010 May;48(5):685-91. doi: 10.1515/CCLM.2010.136.

PMID:
20201743
10.

What is the role of serologic testing in celiac disease? A prospective, biopsy-confirmed study with economic analysis.

Hopper AD, Hadjivassiliou M, Hurlstone DP, Lobo AJ, McAlindon ME, Egner W, Wild G, Sanders DS.

Clin Gastroenterol Hepatol. 2008 Mar;6(3):314-20. doi: 10.1016/j.cgh.2007.12.008.

PMID:
18328437
11.

Serological screening for celiac disease in symptomatic 12 to 36 month-old children.

Modelli IC, Gandolfi L, Almeida RC, Araújo GM, Picanço Mde A, Pratesi R.

Arq Gastroenterol. 2010 Jan-Mar;47(1):61-5.

12.

THE PREVALENCE OF CELIAC DISEASE IN PATIENTS WITH IRON-DEFICIENCY ANEMIA IN CENTER AND SOUTH AREA OF IRAN.

Baghbanian M, Farahat A, Vahedian HA, Sheyda E, Zare-Khormizi MR.

Arq Gastroenterol. 2015 Dec;52(4):278-82. doi: 10.1590/S0004-28032015000400006.

13.

Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease?

Lo Iacono O, Petta S, Venezia G, Di Marco V, Tarantino G, Barbaria F, Mineo C, De Lisi S, Almasio PL, Craxì A.

Am J Gastroenterol. 2005 Nov;100(11):2472-7.

PMID:
16279902
14.

'Pre-endoscopy point of care test (Simtomax- IgA/IgG-Deamidated Gliadin Peptide) for coeliac disease in iron deficiency anaemia: diagnostic accuracy and a cost saving economic model'.

Lau MS, Mooney P, White W, Appleby V, Moreea S, Haythem I, Elias J, Bundhoo K, Corbett G, Wong L, Tsai HH, Cross S, Hebden J, Hoque S, Sanders D.

BMC Gastroenterol. 2016 Sep 15;16:115. doi: 10.1186/s12876-016-0521-5. Erratum in: BMC Gastroenterol. 2016 Oct 5;16(1):122.

15.

[Usefulness of anti-transglutaminase antibodies in the diagnosis of celiac disease].

Fernández ML, Vivas S, Ruiz de Morales JM, Marugán JM.

Gastroenterol Hepatol. 2005 Oct;28(8):437-40. Spanish.

PMID:
16185576
16.

High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase.

Gillett PM, Gillett HR, Israel DM, Metzger DL, Stewart L, Chanoine JP, Freeman HJ.

Can J Gastroenterol. 2001 May;15(5):297-301.

PMID:
11381296
17.

Clinical and Immunologic Features of Ultra-Short Celiac Disease.

Mooney PD, Kurien M, Evans KE, Rosario E, Cross SS, Vergani P, Hadjivassiliou M, Murray JA, Sanders DS.

Gastroenterology. 2016 May;150(5):1125-34. doi: 10.1053/j.gastro.2016.01.029. Epub 2016 Feb 2.

PMID:
26836585
18.

Barriers impeding serologic screening for celiac disease in clinically high-prevalence populations.

Barbero EM, McNally SL, Donohue MC, Kagnoff MF.

BMC Gastroenterol. 2014 Mar 5;14:42. doi: 10.1186/1471-230X-14-42.

19.

Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study.

Carroccio A, Vitale G, Di Prima L, Chifari N, Napoli S, La Russa C, Gulotta G, Averna MR, Montalto G, Mansueto S, Notarbartolo A.

Clin Chem. 2002 Sep;48(9):1546-50.

20.

[Predictive value of serological tests in the diagnosis of celiac disease].

Carroccio A, Di Prima L, Falci C, Le Moli C, Soresi M, Montalto G, Notarbartolo A.

Ann Ital Med Int. 2002 Apr-Jun;17(2):102-7. Italian.

PMID:
12150043

Supplemental Content

Support Center